About Us



About Aquaduct Medical:

Aqueduct Medical Ltd. Alleviates the discomfort and the potential complications to which millions of women each year are exposed when undergoing cervical dilation prior to intrauterine procedures.

Market & Unmet Need:
Approximately 3 million cervical dilations are performed annually in the United States for the purpose of intra-uterine procedures including: abortions, hysteroscopies, and other dilation & curettages. Cervical dilation allows medical practitioners greater access to the inside of the uterus in order to insert surgical tools for the completion of intra-uterine procedures. Until now, there have been primarily two techniques for dilating the cervix. The first technique is the insertion of laminaria (dry, sterile seaweed) into the cervix. When laminaria comes into contact with body fluids, it expands and enlarges the opening of the cervix. Often, this process requires two patient visits and approximately 10-12 hours for sufficient dilation to occur. The second technique, referred to as Hegar dilation, involves the insertion and removal of metal rods that are graduated in increasing diameter. This process is painful, requiring the use of anesthesia, and is associated with a risk of uterine and cervix damage (cervical incompetence).
 
Approximately 3 million cervical dilations are performed annually in the United States for the purpose of intra-uterine procedures including: abortions, hysteroscopies, and other dilation & curettages. Cervical dilation allows medical practitioners greater access to the inside of the uterus in order to insert surgical tools for the completion of intra-uterine procedures. Until now, there have been primarily two techniques for dilating the cervix. The first technique is the insertion of laminaria (dry, sterile seaweed) into the cervix. When laminaria comes into contact with body fluids, it expands and enlarges the opening of the cervix. Often, this process requires two patient visits and approximately 10-12 hours for sufficient dilation to occur. The second technique, referred to as Hegar dilation, involves the insertion and removal of metal rods that are graduated in increasing diameter. This process is painful, requiring the use of anesthesia, and is associated with a risk of uterine and cervix damage (cervical incompetence.
 
Aqueduct Medical Ltd. is an Israeli start-up company founded in August, 2013 and operates within the NGT technology incubator. The company specializing in the research and development of advanced Obstetric/Gynecological tools. Aqueduct -100, the company’s first product is a cutting-edge, innovative cervical dilator that combines the benefits of laminaria and Hegar Rods (the current methods) through lower risk of uterine perforation, lower rate of cervical incompetence, elimination of need for general anesthesia, and reduced number of patient visits.